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greater amplitude of far field potentials when performing catheter ablation in the left 
superior pulmonary vein. The results of this study also demonstrate that pulmonary vein 
anatomy is highly variable and that a different pattern of branching exists between the 
right and left pulmonary veins. 
11:30 a.m. 
859-5 Randomized Evaluation of the Utility of Intracardlac 
Echocardiogrsphy for AV Node Interventions 
~ ,  David Schwartzman, Atrial Arrhythmla Center, University of Pittsburgh, 
Pittsburgh, Pennsylvania. 
Background: The value of intracardiac echocardiography (ICE) for guiding transvenous 
catheter ablation procedures which target the AV node complex is unclear. Methods: The 
ICE catheter utilized incorporated a rotating transducer operating at 9 MHz (Boston Sci- 
entific). Patients undergoing complete AV node ablation (AVN, n=30) or slow pathway 
ablation (SP, n=10) were randomly assigned to ICE-guided or standard (eg. fluoroscopy/ 
electrogram-guided) technique. In the standard groups, ICE images were recorded but 
were unavailable to the operator for review until after the case. Results: (table shows 
median values; *p<.05 versus compadson group): All procedures were acutely success- 
ful. Total procedure duration, radiofrequency power, and ablation electrode maximum 
temperature were not significantly different. Based on the ICE images, in the standard 
groups the principal reason for individual esion failure was poor/unstable ablation elec- 
trode-endocardial contact. Intraprocedurally, in the AVN cohort 1 patient in the standard 
group required crossover to ICE. During followup (at least 6 months in each patient): in 
the AVN cohort 2 patients in the standard group experienced recurrence of AV nodal con- 
duction; in the SP cohort 1 patient in the ICE group expedencad spontaneous recurrence 
of AV nodal reentry. Conclusions: For catheter ablation or modification of the AV node, 
relative to standard technique the ICE-guided technique reduced fluoroscopy exposure 
and ablation lesion burden. 
AVN-iCE AVN-Standard SP-ICE SP-Standard 
Patients (n) 15 15 5 5 
Fluoro "rime (min) 0.0 * 3.1 0.2 * 5.5 
RF Lesions (n) 1 * 3 1 * 3 
11:45 a.m. 
859-6 Four Vessel Pu lmonary Vein Isolation Guided by Intra- 
Cardiac Echocardiography Without Contrast 
Venography In Patients With Drug Refractory 
Paroxysmal Atrial Fibrillation 
Viiendra Swaruo. Koji Azegemi, Mauricio S. Arruda, Martin C. Burke, Albert C. Lin, David 
J. Wilber, University of Chicago Hospitals, Chicago, Illinois. 
Background: Pulmonary vein (PV) isolation requires accurate definition of PV anatomy. 
Venography is time consuming and increases exposure to contrast and radiation. We 
present our experience with intracardlac echocardiography (ICE) to image and guide 
empiric isolation of all four PV without venography. Methods: 24 pts (age 49±10.6 yrs) 
with refractory paroxysmal atrial fibrillation (PAF) underwent circumferential mapping 
(Lasso, Biosense/Webster) and isolation of all four pulmonary veins with radiofrequency 
ablation. ICE (Acuson) was used to guide transseptal puncture, and determine PV diam- 
eters and flow velocities before and after ablation. During ablation, ICE was utilized to 
monitor catheter positioning. Results: All veins were successfully imaged by ICE and 
electrically isolated as documented by post ablation PV mapping. Mean duration of trans- 
septal catheterization was 134 ± 35 rain and fluoroscopy time was 41.8 -+ 13 min. There 
were only minor changes in PV diameters and flow velocities immediately post proce- 
dure. Spiral CT images at 3 months did not demonstrate PV stenosis or occlusion in any 
pt. No PAF was documented in 19/24 pts (79%) during short-term follow-up 
LtSuperior Lt Inferior Rt Superior Rt Infedor 
PV PV PV PV 
Diameter (cm) Pre 1.4 ± 0.2 1.6 + 0.2 1.7 ± 0.4 1.5 ±0.3 
Post 1.2 + 0.2 1.5 ± .2 1.6 ± 0.4 1.3 + 0.3 
PeekVeloclty(m/sec) Pro 0.56:t:0.15 0.53±0.13 0.56+0.18 0.46+0.09 
Post 0,75 ± 0.3 0.68 ± 0.26 0.59 + 0.15 0.56 + 0.12 
Conclusion: Exclusive use of ICE without venography to guide ablation of all four pulmo- 
nary veins is a feasible and practical strategy. Continuous reel-time guidance of energy 
delivery at the PV ostium may enhance both the safety and effectiveness of 4 vessel iso- 
lation relative to other imaging techniques. 
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1185-103 Associat ion of Angiotenein Convert ing Enzyme Gene 
Polymorphlam With Tachycardia Cardlomyopethy 
Pramod M. Deshmukh, John D. Noti, Mary A. Romanyshyn, Guthrie Clinic, Ltd, Say'e, 
Pennsylvania, Guthrie Research Institute, Sayre, Pennsylvania. 
Background: Insertion/deletion (I/D) polymorphism of angiotensin converting enzyme 
(ACE) gene has been implicated in ischemic and non-ischemic cardiomyopathy. How- 
ever, its relation to tachycardia cardiomyopathy is unknown. 
Methods: Twenty patients with persistent echycardla nd cardiomyopathy with ejection 
fraction (EF) 20 ± 7% showed improvement in EF to 43 ± 9% (p < 0.001) after interven- 
tions for rate control (Group A, tachycardla cardiomyopathy). A separate group of 
patients with a history of atrial arrhythmlas of 16 ± 15 months required interventions for 
rate control but maintained normal EF of 49 ± 5% (Group B, tachycardia without cardi- 
omyopathy). We compared I/D genotype frequency of Group A and B with that of healthy 
normal volunteers (Group C). 
Results: Gene frequency was significantly different in Groups A, B, and C (p < 0.002). 
Group A was significantly different from Group B (p < 0.035) and Group C (p < 0.009). 
Despite improvement, Group A's EF of 43% was significantly lower than Group B's EF of 
49% (p < 0.02). 
Conclusion: I/D poiymorphism of ACE gene may account for cardiomyopathy second- 
ary to tachycardla. 
1185-104 Assessment of Therapeutic Efficacy in 
Neurocardiogenic Syncope: Clomlprsmine Versus 
Isoproterenol Tilt Test 
Gaor?e N. Thendorakis, Dionyssios Leftheriotis, Efthimios G. Uvanis, Panagiota Flevari, 
Elias Zarvalis, Dimitrios T. Kramastinos, Onassis Cardiac Surgery Center, Athens, 
Greece. 
Background: In patients (pts) with recurrent neurocardiogenic syncope (NCS), evaluation 
of therapeutic efficacy by repeated heed-up tilt testing (HUT) with isoproterenot as drug 
challenge is questioned. Clomipramine has also been used dudng HUT for the diagnosis 
of NCS. In this study, we prospectively compared ciomipramine HUT with isoproterenol 
HUT in order to evaluate their relative efficacy in assessing response to treatment. Meth- 
ods: We studied 46 pts (17 men, 29 women, mean aged 36±17 years) with history of 
recurrent NCS and two consecutive positive HUTs (HUTs-I), one with clomipramine and 
the other with isoproperonoL The two tests were performed in a randomized sequence 
and an 24-hour interval was interspersed between them. Our pts were randomly treated 
with fiuoxetine or propranolol for 6 months and then the two HUTs were repeated in the 
same sequence (HUTs-2). We recorded the number of syncopal attacks during the last 6 
months before therapy and during the 6 months of treatment. We also examined whether 
the decrease in syncopal episodes during therapy was associated with the response to 
each of HUTs-2. Results: Fluoxetine and propranolol were equally effective in reducing 
syncopal attacks (4.0~1.8 before therapy vs 1.3±0.8 during therapy for fluoxetine and 
3.8±1.6 vs 1.1±1.5 respectively for propranolol, p:NS). Following therapy, a negative clo- 
mipramine HUT-2 was associated with a greater decrease in syncopal episodes (4.0±1.7 
vs 0.9¢1.2) than a positive clomipramine HUT-2 (3.9±1.3 vs 1.4±1.1), p<0.01. No such 
difference was observed between pts with a negative isoproterenol HUT-2 (3.9±1.2 vs 
1.2±1.1 ) and those with a positive isoproterenol HUT-2 (4.0±1.3 vs 1.0±1.0). Conclusion: 
In patients with NCS, clomipremine*HUT depicts therapeutic efficacy more accuretly than 
isoproterenoI-HUT. his may have important clinical implications. 
1185-105 Prevalence of Self-Reported Syncope: An 
Epidemiologic Study From Olmsted County, MN 
Lin Y. Chen, Win K. Shen, Douglas W. Mahoney, Steven J. Jacobsen, Richard J. 
Rodeheffer, Mayo Clinic, Rochester, Minnesota. 
Background: Although syncope is a common clinical syndrome with significant prognos- 
tic, psychosocial and economic implications, our current understanding of the prevalence 
of syncope is based on a few small studies in the past, and from very selected popula- 
tions. In this study, we estimated the prevalence of syncope in a cross-sectional survey 
of the adult population of OImsted County, MN. Methods: Residents of Olmstad County, 
MN >45 years of age were randomly sampled to take part in a cross-sectional study of 
left ventricular function in a population. A detailed questionnaire, which included ques- 
tions pertaining to syncope, was administered to the participants of the parent study. 
Subjects were specifically asked to respond to the following question, "Have you ever 
experienced a black-out?" The prevalence of syncope was estimated as the number of 
self-reported cases divided by the number responding to the questionnaire. The associa- 
tion of syncope prevalence with patient characteristics was investigated using a chi- 
square test of independence for categorical data and a chi-squara test of trend for ordinal 
data. Results: A total of 1925 subjects responded to the questions related to syncope. 
The median age of the participants was 61 years (Q1=53, Q3=71) and 905 (47.0%) were 
male. Overall, 364 subjects reported an episode of syncope in their lifetime giving a 
crude estimated prevalence of 19% (95% CI: 17% to 21%). There was no statistically sig- 
nificant association of syncope prevalence with age (p=0.86). Females reported a higher 
prevalence of syncope (22% vs. 15%, p<0.01 ). The median age of onset of syncope was 
25 years (Q1=15, Q2=50) with 47% having at least one recurrence. Females tended to 
report more recurrent episodes of syncope than males (51% vs. 41%), but this was not 
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statistically significant (p=0.03). Conclusions: The prevalence of syncope is estimated 
at 19% in the general population. Females have a higher prevalence and tend to have 
more recurrences. The fact that prevalence is not greater in the older age groups may 
suggest a higher mortality rate in the elderly, but further investigations are needed. 
Results of this study can serve as bench mark information for future epidemiologic stud- 
ies. 
1185-106 Cl in ical  Ut i l i ty of  an Adenosine-Nitroglycerin Tilt Test 
Protocol 
Suneet MittaL Edward J. McNulty, Kenneth M. Stein, Steven M. Markowitz, David J. 
Slotwiner, Sei Iwai, Mithilesh K. Das, Jennifer D. Cohen, Steven C, Hao, Bruce B. 
Lerman, NY Hospital-Cornel/Medical Center, New York, New York. 
Background: We previously described the utility of adenosine (ADO) based tilt testing, 
whose advantage is that it can be completed within 3 minutes. To increase the yield of 
the tilt test, we initially incorporated an additional 15 rain isoproterenol (ISO) tilt in ADO 
negative pts. However, the poor specificity (85% at our institution) of the ISO tilt limited 
the clinical utility of this approach. Recently, a nitroglycerin (NTG) based tilt protocol has 
gained acceptance. We, therefore, sought to evaluate the utility of a tilt protocol incorpo- 
rating both ADO and NTG. 
Methods: We evaluated 100 consecutive pts (44 M, 50 ± 17 yrs) who underwent an 
ADO-NTG tilt between Jan-July 2001. Patients were tilted at 60 ° and given 150 mcg/kg 
ADO (10 ± 3 mg) and observed for 3 min. After an initial period of sinus slowing and/or 
AV block, all pts developed a reflex sinus tachycardia. In pts prone to vasovagal syncope 
and a positive ADO tilt, sinus tachycerdia was followed by symptomatic bradycardia and/ 
or hypotension. If the ADO tilt was negative, the patient, while remaining upright, was 
given 400 mcg SL NTG and observed for an additional 15 minutes. To determine test 
specificity, 30 control pts (21 M, 30 ± 9 yrs) underwent an ADO tilt (12 ± 2 mg) and 15 
control pts (11 M, 29 ± 8 yrs) underwent a NTG tilt. 
Results: 20 (20%) pts had a positive ADO tilt. Of the 80 pts with a negative ADO tilt, 38 
(48%) had a positive NTG tilt at 7±3 min. However, the specificity of the NTG tilt was only 
47% (8/15 controls were positive), in contrast, the specificity of the ADO tilt was 100% 
(all 30 controls were negative). 
Conclusions: The ADO tilt, which takes only 3 min to complete, provides a moderate 
diagnostic yield with very high test specificity. In contrast, although the NTG tilt has a high 
diagnostic yield, its poor specificity greatly limits its clinical utility. 
11 85-113 Demonst ra t ion  of  the Exact Anatomical Tachycerdla 
Circuit of the Typical Atrial Flutter Using Entrainment 
Mapping 
Hiroshioe Yamabe. Megumi Yamamuro, Toshiaki Yoshida, Yasuhiro Morikami, Yoshihiro 
Kimura, Youichi Hokamura, Kumamoto City Hospital, Kumamoto, Japan. 
Background;The precise reentrant pathway in typical atrial flutter (AF) has not been fully 
elucidated. Methods;To define the tachycerdia circuit, entrainment mapping was per- 
formed during AF both around the crista terminalis (CT) and tricuspid annulus (TA) in 17 
pts. Entrainment mapping was performed at the superior (S-ACT), middle (M-ACT) and 
inferior (I-ACT) third of the anterior CT (ACT), superior (S-PCT), middle (M-PCT) and 
inferior (I-PCT) third of the posterior CT (PCT) and the anterior (A-TA), lateral (L-TA), 
posterior (P-TA) and septal (S-TA) portions of the TA. The first post pacing interval (FPPI) 
was used as an index of proximity to the circuit. Results;The mean AF cycle length 
(AFCL) was 239±27 ms. Double potentials, indicating the conduction block at the CT, 
was observed along the CT in all pts. The FPPI at the A-, L-, P- and S-TA did not differ 
from the AFCL (239±27, 241±27, 240±27 and 239±27 ms, respectively) in all pts. The 
FPPI at the S-, M- and t- were signifiicantly longer than the AFCL (278±33, 273±32 and 
269±33 ms, respectively, p<0.01) in all pts, however, the FPPI at the S-, M- and I-ACT 
were divided into two groups. The FPPI at the S-, M- and I-ACT did not differ from the 
AFCL in 9 pts (242¢34, 242±34 and 241±34 ms, respecUvely)(Group 1) but were signifi- 
cantly longer than the AFCL in the remaining 8 pts (278±22, 269±22 and 262±18 ms, 
respectively, p<0.01)(Group 2). During entrainment from I-ACT, the first and the second 
components of the double potentials recorded at I-ACT were fused and thus the short cut 
conduction across the CT was observed both in Group 1 an 2. However, the FPPI was 
longer than the AFCL in group 2. These indicate that the presence of conduction block 
along the CT was not essential for the perpetuation of AF in Group 2. The CT and the TA 
were both an essential part of the reentry cimuitn in Group 1, however, the CT was con- 
sidered to be a bystander and the reentrant wavefront ciculatad only around the TA in 
Group 2. Conclusion;Two types of reentrant circuit exist in typical AF. The CT and the TA 
are both an essential pathway of the reentry circuit in one group. However, the CT acts 
as a bystander during AF and the reentrant wavefront ciculates only around the TA in 
another group. 
1185-114 Symptomatic Status Does Not Predict Morta l i ty  in Atr ia l  
F lutter  
Humberto Vidaillet, Ichiro Suzuki, Juan Granada, Po-Huang Chyou, Mario Ortiz, Param 
Sharma, Peter N. Smith, Karen Maassen, Kelley Anderson, John Hayes, Marshfield 
Clinic, Marshfield, Wisconsin. 
Background: Atrial flutter (Afltr) is associated with an increased mortality risk. Despite 
its proven safety and efficacy in Afltr, radiofrequency ablation (RFA) is typically reserved 
for highly symptomatic patients (pts) with drug refractory disease. To evaluate the appro- 
priateness of the current emphasis placed of symptoms as a determinant of RFA, we 
determined the impact of symptomatic status on the mortality risk of pts diagnosed with 
Afltr in the general population, Methods: We used the resources of the Marshfield Epide- 
miologic Study Area, a database that captures nearly all medical care and deaths among 
its 58,820 residents, to identify all incident cases of Afltr diagnosed from 1991 to 1995. 
The only exclusion criteria were the presence of medical conditions precluding ascertain- 
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ment of symptoms at the time of initial Afltr diagnosis. Using death from any cause as the 
primary endpoint, we compared the mortality risk of symptom status (symptomatic versus 
asymptomatic) after adjusting for age, gender, heart failure, chronic obstructive pulmo- 
nary disease, diabetes mellitus, myocardial infarction, smoking history, cerebral embo- 
lism, hypertension, rheumatic heart disease, thyroid abnormality and concurrent atrial 
fibrillation. Results: Among a total of 170 incident cases of Afltr; 92 (54%) were symp- 
tomatic and 78 (46%) were asymptomatic. There were no significant differences between 
the two groups in their respective prevalence of preexisting conditions. Follow-up was 
completed in 100% of cases (mean, 3.7 yr., max. 6.9 yr.). At last follow-up, 84 (49%) of all 
Afltr patients had died. These included 50% of symptomatic and 43% of asymptomatic 
cases (P=NS). After adjusting for baseline characteristics, a multivariate analysis showed 
no differences in the mortality risk of the two groups (RR 1.18, 95 percent CI, 0.73 to 
1.91, P=0.503). Conclusions: 1) Symptomatic status does not predict mortality risk in 
Afltr. 2) Our data challenge the validity of using symptoms as a primary indication of RFA 
in AfRr. 3) These findings provide additional support for the need of further research to 
determine optimal utilization of curative technologies in all cardiac arrhythmias. 
1185-115 Anatomical Characteristics of the Pulmonary Vein 
Ending Into the Left Atrium: Relevance for  
Radiofrequency Ablation of Atrial Fibrillation 
Josd Anoel Cabrera. Damidn Sanchez-Quintana, Yen Ho, Fernando Cabestrero, Josd 
Manuel Rubio, Felipe Navarro, Robert Anderson, Jer6nimo Farr~, Fundacidn Jimdnez 
D/az, Madrid, Spain, Facultad de Medicina. UNEX, Badajoz, Spain. 
Background: Radiofrequency pulses applied circumferanciafly around the orifices of the 
pulmonary veins (PV) has been reported to prevent recurrences in patients with paroxys- 
mal and permanent atrial fibrillation (AF). This study is aimed at examining the PV-atrial 
junction in 35 normal human autopsied hearts from adults (52±18 years, 24 males). 
Results: In 29 (83%) heads there were 4 PV. Two hearts (6%) had a single left PV 
(branching at the hilium level) and in 4 hearts (11%) we found 5 PV. Only 57% of the 
heads have four individualized endings of the PV into the left atrium. Nine hearts (26%) 
had a common ending for the 2 left PV (8) or the 2 right PV (1) into a "vestibule" in the left 
atrium. The diameter of the vestibule was 19.5±3 mm (range 18-24 ram) and the length 
was between 5 to 14 mm. In hearts with 4 PV orifices, the diameter of the ostium at the 
PV-atrial junction was 12.5±3 mm (range 7-17 ram) and in the two heads with a single left 
PV was 26 and 28 mmm respectively. In 18 heads the separation between one of the 
superior and inferior PV ostia was < 3 mm wide. The distances between the orifices of 
the right PV ranged from 2 to 11 mm (mean 6.5±2 mm) and 2 to 16 mm (mean 8.4±2 
mm) for the left PV respectively, 
Conclusions: The PV-atrial junction is more than a simple presence of 4 PV orifices, A 
common ending into the left atrium (26% of hearts), the existence of a large vestibule and 
the presence of a thin inter-orifice left atrial rim (in 53% of our specimens) are relevant 
anatomic features for radiofrequency procedures around the PV ostia in patients with AF. 
1185-116 Noncontact Mapping of Right Atrial Activation During 
Pulmonary Vein Pacing 
Pugezhendhi Vijayaraman, Soo G. Kim, Jay N, Gross, Kevin J. Ferrick, John D. Fisher, 
Euoen C. Palma, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, 
New York. 
When the posterior left atrium is paced, right atriat activation has previously been 
described over three breakthrough points: Bachman's bundle (BB), Fossa (FO) and Cor- 
onary sinus os (CS), We used a noncontact mapping system using a balloon catheter to 
record the right atrial activation patterns during right and left pulmonary vein (PV) pacing 
in six patients (WPW 3, Left Atrial tachycardia 1, AF 1, AVNRT 1). Twenty-six PV were 
paced at threshold from the distal PV where PV potentials were recorded. Anatomy was 
confirmed by PV angiography. 
RESULTS: Sites of earliest right atrial activation are tabulated below: 
Patient LUPV LLPV RUPV RLPV RMPV 
1 BB-CS BB-CS BB FO 
2 BB BB FO FO-BB FO-BB 
3 BB-CS CS-BB BB PRA* PRA 
4 CS CS PRA PRA 
5 CS CS PRA PRA 
6 BB CS-BB PRA PRA 
Pacing 11.6 mA @ 11.5 mA @ 15 mA @ 12.6 mA @ 8mA @ 0.8 
thmshold 0.8 ms 0.6 ms 0.8 ms 0.8 ms ms 
*PRA: Posterior Right Atrium 
CONCLUSIONS: The earliest right atrial activation can occur nearly simultaneously over 
two discrete points when the pulmonary veins are paced. Direct posterior right atrial cap- 
ture can occur when pacing distal right but not left pulmonary veins. No pattam of right 
atrial activation predicts the PV being paced. This could have implications in the therapy 
of atrial fibrillation arising from the PV. 
